An antioxidant role for calcium antagonists in the prevention of adrenaline mediated myocardial and endothelial damage
- PMID: 2054241
- PMCID: PMC1024675
- DOI: 10.1136/hrt.65.6.322
An antioxidant role for calcium antagonists in the prevention of adrenaline mediated myocardial and endothelial damage
Abstract
Objective: To investigate the mechanism of calcium antagonist mediated cytoprotection against the damaging effects of adrenaline in vivo on cardiac myocytes and human endothelial cells from the umbilical vein.
Methods: Human endothelial cells cultured from the umbilical vein and isolated rat cardiac myocytes were treated with plasma from rats given adrenaline 30 minutes previously with pretreatment with calcium antagonists and without. The effect on indices of cell damage that suggest oxidation stress was determined.
Results: Pretreatment of rats with calcium antagonists before adrenaline administration largely inhibited the cytotoxic effects of their plasma on the two target cells used. Plasma taken from animals not pretreated with calcium antagonists caused release of oxidised glutathione from cells, a fall in intra-cellular reduced glutathione concentration, a fall in ATP production, and release of angiotensin converting enzyme from the endothelial cells.
Conclusion: Calcium antagonists protect against the cardiotoxic effects of catecholamine by preventing the generation of plasma borne cytotoxic compounds, which are probably free radicals.
Similar articles
-
Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.Med Sci Monit. 2001 Jan-Feb;7(1):1-16. Med Sci Monit. 2001. PMID: 11208485
-
Epinephrine-induced cytotoxicity of rat plasma. Its effects on isolated cardiac myocytes.Lab Invest. 1988 Dec;59(6):817-23. Lab Invest. 1988. PMID: 3199796
-
[Prevention of adrenaline-induced heart damage using the antioxidant ionol].Biull Eksp Biol Med. 1984 Jul;98(7):16-8. Biull Eksp Biol Med. 1984. PMID: 6466817 Russian.
-
Angiotensin-converting enzyme inhibitors, calcium blockers, estrogen and antioxidants in secondary prevention of coronary disease.Can J Cardiol. 1998 Jul;14 Suppl D:8D-10D. Can J Cardiol. 1998. PMID: 9713419 Review.
-
A rationale for treatment of endothelial dysfunction in hypertension.J Hypertens Suppl. 1999 Feb;17(1):S25-35. J Hypertens Suppl. 1999. PMID: 10340841 Review.
Cited by
-
Atherosclerosis: inhibition of regression as therapeutic possibilities.Br Heart J. 1991 Jun;65(6):302-10. doi: 10.1136/hrt.65.6.302. Br Heart J. 1991. PMID: 2054238 Free PMC article. Review. No abstract available.
-
Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension.J Clin Biochem Nutr. 2007 Mar;40(2):141-7. doi: 10.3164/jcbn.40.141. J Clin Biochem Nutr. 2007. PMID: 18188416 Free PMC article.
-
Effect of mebudipine on oxidative stress and lipid peroxidation in myocardial ischemic-reperfusion injury in male rat.J Res Med Sci. 2012 Dec;17(12):1150-5. J Res Med Sci. 2012. PMID: 23853633 Free PMC article.
-
Modification of atherosclerosis by agents that do not lower cholesterol.Br Heart J. 1993 Jan;69(1 Suppl):S54-62. doi: 10.1136/hrt.69.1_suppl.s54. Br Heart J. 1993. PMID: 8427766 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical